Jiangxi Hongyuan Pharmaceutical Co., Ltd., commonly referred to as Hongyuan Pharma, is a prominent player in the pharmaceutical industry, headquartered in Jiangxi, China. Established in 2001, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of traditional Chinese medicine and modern pharmaceuticals. With a strong operational presence across various regions in China, Hongyuan Pharma is renowned for its innovative formulations and commitment to research and development. The company’s core offerings include a diverse range of active pharmaceutical ingredients (APIs) and finished dosage forms, distinguished by their efficacy and safety profiles. Recognised for its dedication to quality and compliance with international standards, Jiangxi Hongyuan Pharmaceutical has positioned itself as a trusted supplier in both domestic and global markets, achieving notable milestones in product development and market expansion.
How does Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Jiangxi Hongyuan Pharmaceutical Co., Ltd.'s score of 20 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Jiangxi Hongyuan Pharmaceutical Co., Ltd., headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Jiangxi Hongyuan Pharmaceutical is addressing climate change or its carbon footprint. The absence of such information may reflect a broader industry context where many companies are still developing their sustainability strategies and emissions reporting frameworks. In summary, Jiangxi Hongyuan Pharmaceutical Co., Ltd. has not disclosed any carbon emissions data or climate commitments, indicating potential areas for future development in environmental responsibility and sustainability practices.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jiangxi Hongyuan Pharmaceutical Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.